Transfer RNA derived fragment, tRF-Glu-CTC, aggravates the development of neovascular age-related macular degeneration
Liang Yu, Lingjie Kong, Yuelu Zhang, Yihan Zhang, Mingsu Shi, Jiaqiu Huang, Hongyu Kong, Siyi Qi, Yunlong Yang, Jiaxu Hong, Meidong Zhu, Xiangjia Zhu, Xinghuai Sun, Shujie Zhang, Lianqun Wu, Chen Zhao
Abstract
This study demonstrated the important role of tRF-Glu-CTC in the progression of angiogenesis. Targeting of tRF-Glu-CTC may be an alternative to current anti-VEGF therapy for CNV in AMD and other conditions with angiogenesis.
Topics & Concepts
Macular degenerationChoroidal neovascularizationAngiogenesisCancer researchAngiogeninBiologyNeovascularizationMolecular biologyPathologyMedicineOphthalmologyCancer-related molecular mechanisms researchRNA modifications and cancerMicroRNA in disease regulation